Your browser doesn't support javascript.
loading
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
Bergerot, Cristiane Decat; Philip, Errol J; Bergerot, Paulo Gustavo; Hsu, JoAnn; Dizman, Nazli; Salgia, Megan; Salgia, Nicholas; Vaishampayan, Ulka; Battle, Dena; Loscalzo, Matthew; Dale, William; Pal, Sumanta Kumar.
Afiliação
  • Bergerot CD; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Philip EJ; University of California San Francisco, San Francisco, California.
  • Bergerot PG; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Hsu J; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Dizman N; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Salgia M; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Salgia N; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Vaishampayan U; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan.
  • Battle D; Kidney Cancer Research Alliance, Alexandria, Virginia.
  • Loscalzo M; Department of Supportive Care, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Dale W; Department of Supportive Care, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Pal SK; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.
Cancer ; 127(3): 354-358, 2021 02 01.
Article em En | MEDLINE | ID: mdl-33007114
ABSTRACT

BACKGROUND:

Patient-reported outcomes have been used to assess treatment effectiveness and actively engage patients in their disease management. This study was designed to describe the patient-reported performance status (PS) and the provider-reported PS.

METHODS:

Patients with metastatic genitourinary cancers were recruited from a single cancer center before the initiation of a new line of treatment. PS (Eastern Cooperative Oncology Group [ECOG]), quality of life (Functional Assessment of Chronic Illness Therapy-General), and distress (Patient-Reported Outcomes Measurement Information System Anxiety and Depression) were self-reported by patients. Clinical data (eg, age, sex, diagnosis, and physician-reported ECOG PS) were extracted from medical records. Multivariate analysis was used to determine the association between PS, quality of life, and psychological symptoms.

RESULTS:

One hundred forty-five patients were enrolled (76.6% male, 70.3% White, 81.4% married, and 76.6% well educated). The median age was 67 years; 66.9% were diagnosed with renal cell carcinoma, 20.0% were diagnosed with urothelial carcinoma, and 13.1% were diagnosed with prostate cancer. Clinicians more frequently classified patients' ECOG PS as 0 in comparison with the patients themselves (92.4% vs 64.1%; P = .001). Higher clinician-reported ECOG PS was associated with poorer physical and functional well-being and higher rates of depression (P < .01), whereas higher patient-reported ECOG PS was associated with worse psychosocial outcomes (P < .01).

CONCLUSIONS:

Discrepancies were noted between the patient- and provider-reported ECOG PS, with clinicians overestimating the ECOG PS in comparison with the patients themselves. This study's findings suggest that patients incorporate their social and emotional well-being into their PS score in addition to their physical well-being. This information is not immediately accessible to most clinicians from just a standard patient interview and likely accounts for the overestimation of the patients' ECOG PS by the clinicians.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urogenitais / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urogenitais / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article